Published on
November 12, 2024
- 00:44 GMT
Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults
ADELAIDE, SOUTH AUSTRALIA, AUSTRALIA, November 12, 2024 /EINPresswire.com/ -- GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
